![David Venables](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Venables
Algemeen Directeur bij
Synpromics Ltd.
Profiel
Dr. David C.
Venables is a Chief Executive Officer & Director at Laverock Therapeutics Ltd. and a Chief Executive Officer at Synpromics Ltd. He is on the Board of Directors at Laverock Therapeutics Ltd. Dr. Venables was previously employed as a Chief Executive Officer, Director & MD by Anatara Lifesciences Ltd., a Non-Executive Director by Ark Therapeutics Group Plc, a Chief Operating Officer by Intercell USA, Inc., a Head-Process Development by Medeva Plc, and an Operations Director by Q-One Biotech Ltd. He received his doctorate degree from the University of Surrey.
Actieve functies van David Venables
| Bedrijven | Functie | Begin |
|---|---|---|
Synpromics Ltd.
 Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Algemeen Directeur | - |
Laverock Therapeutics Ltd.
 Laverock Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel therapeutics for cell, gene & oncology therapeutics | Algemeen Directeur | 01-08-2021 |
Eerdere bekende functies van David Venables
| Bedrijven | Functie | Einde |
|---|---|---|
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Directeur/Bestuurslid | 27-02-2015 |
| ANATARA LIFESCIENCES LTD | Algemeen Directeur | 24-02-2015 |
Q-One Biotech Ltd.
 Q-One Biotech Ltd. BiotechnologyHealth Technology Provides specialist safety testing, process validation, and contract manufacturing services of cell banks, vaccines and gene therapy products to the biopharmaceutical industry | Corporate Officer/Principal | - |
Medeva Plc
 Medeva Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company for the development, manufacture and sale of pharmaceutical products | Corporate Officer/Principal | - |
| IOMAI CORPORATION | Operationeel Directeur | - |
Opleiding van David Venables
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
35
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Medeva Plc
Medeva Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company for the development, manufacture and sale of pharmaceutical products | Health Technology |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Commercial Services |
Q-One Biotech Ltd.
Q-One Biotech Ltd. BiotechnologyHealth Technology Provides specialist safety testing, process validation, and contract manufacturing services of cell banks, vaccines and gene therapy products to the biopharmaceutical industry | Health Technology |
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anatara Lifesciences Ltd.
 Anatara Lifesciences Ltd. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic oral solutions for gastrointestinal diseases in animals and humans | Health Technology |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Process Industries |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel therapeutics for cell, gene & oncology therapeutics | Commercial Services |
